Minimal Residual Disease (MRD) Testing Market: Redefining Precision Oncology in 2025
Cancer care is entering a new era—one where detection is more precise, treatments are more personalized, and survival outcomes are dramatically improving. At the center of this transformation is Minimal Residual Disease (MRD) testing, one of the fastest-growing and most impactful innovations in precision oncology. In 2025, the global MRD testing market is accelerating rapidly, driven by advancements...